{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:46:17Z","timestamp":1794473177319,"version":"4.9.1"},"reference-count":53,"publisher":"American Chemical Society (ACS)","issue":"21","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32201053"],"award-info":[{"award-number":["32201053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1530141"],"award-info":[{"award-number":["U1530141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012236","name":"Beijing Institute of Technology Research Fund Program for Young Scholars","doi-asserted-by":"publisher","award":["3100012222222"],"award-info":[{"award-number":["3100012222222"]}],"id":[{"id":"10.13039\/501100012236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Targeted protein degradation via PROTACs holds promise for antiviral therapy but is challenged by inefficient ternary complex formation. We report the de novo design of PROTACs targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp). Leveraging repurposed antiviral scaffolds and optimizing E3 ligase ligands, we designed and screened 600 candidates. Our integrated pipeline identified PROTAC 10, a molnupiravir-CRBN conjugate, which demonstrated high-affinity binding (Kd = 1.09 nM), pronounced positive cooperativity (\u03b1 = 45.9), and effective CRBN-mediated RdRp degradation (DC50 = 1.97 \u03bcM) in infected cells. PROTAC 10 was synthesized by using modular click chemistry (CuAAC), strategically incorporating a central triazole ring flanked by flexible alkyl spacers. It exhibited potent antiviral activity (IC50 = 3.12 \u03bcM). Molecular dynamics simulations revealed that its engineered linker enhances cooperativity, ternary complex stability (\u0394GTER = \u2212247 kcal\/mol), and chameleonic character. This study provides a strategic framework to design antiviral PROTACs through rational linker optimization that enables selective viral protein degradation.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c02065","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:13:32Z","timestamp":1762319612000},"page":"23247-23266","source":"Crossref","is-referenced-by-count":6,"title":["Structure-Informed\nDesign of High-Cooperativity PROTAC\nTargeting SARS-CoV-2 RdRp via Click Chemistry and Enhanced\nSampling Simulations"],"prefix":"10.1021","volume":"68","author":[{"given":"Kiran","family":"Shehzadi","sequence":"first","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ran","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Kalsoom","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-0201","authenticated-orcid":true,"given":"Jingyue","family":"Dong","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1432-1249","authenticated-orcid":true,"given":"Irfan","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-7476","authenticated-orcid":true,"given":"Ming-Jia","family":"Yu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2751-0057","authenticated-orcid":true,"given":"Zihui","family":"Meng","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-8521","authenticated-orcid":true,"given":"Jian-Hua","family":"Liang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Technology , , ,","place":["Beijing, China, 10081"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"1","key":"2026073103245791700_cit1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","article-title":"PROTACs: great opportunities for\nacademia and industry (an update from 2020 to 2021)","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Therapy."},{"key":"2026073103245791700_cit2","doi-asserted-by":"publisher","first-page":"115037","DOI":"10.1016\/j.ejmech.2022.115037","article-title":"PROTACS: a technology\nwith a gold rush-like atmosphere","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med.\nChem."},{"key":"2026073103245791700_cit3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41587-021-01173-2","article-title":"The PROTAC\ngold rush","volume":"40","author":"Garber","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"2026073103245791700_cit4","doi-asserted-by":"publisher","first-page":"105848","DOI":"10.1016\/j.bioorg.2022.105848","article-title":"Advances and\nperspectives\nof proteolysis targeting chimeras (PROTACs) in drug discovery","volume":"125","author":"Xi","year":"2022","journal-title":"Bioorg. Chem."},{"key":"2026073103245791700_cit5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","article-title":"Targeted protein degradation by PROTACs","volume":"174","author":"Neklesa","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"2026073103245791700_cit6","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100270","article-title":"Recent developments\nin PROTAC-mediated protein degradation:\nfrom bench to clinic","volume":"23","author":"Hu","year":"2022","journal-title":"ChemBiochem"},{"key":"2026073103245791700_cit7","doi-asserted-by":"publisher","first-page":"106720","DOI":"10.1016\/j.bioorg.2023.106720","article-title":"Unlocking the potential of PROTACs:\nA comprehensive\nreview of protein degradation strategies in disease therapy","volume":"139","author":"Bhole","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"17","key":"2026073103245791700_cit8","doi-asserted-by":"publisher","first-page":"11454","DOI":"10.1021\/acs.jmedchem.2c00844","article-title":"Progress and challenges in targeted\nprotein degradation for neurodegenerative disease therapy","volume":"65","author":"Fang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026073103245791700_cit9","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1038\/s41467-019-11429-w","article-title":"Small molecule degraders\nof the hepatitis C virus protease reduce susceptibility to resistance\nmutations","volume":"10","author":"de Wispelaere","year":"2019","journal-title":"Nat. Commun."},{"key":"2026073103245791700_cit10","doi-asserted-by":"publisher","first-page":"112711","DOI":"10.1016\/j.ejmech.2020.112711","article-title":"The development\nof Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020","volume":"206","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026073103245791700_cit11","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1038\/s41467-024-49161-9","article-title":"Broad-spectrum activity\nagainst mosquito-borne flaviviruses achieved\nby a targeted protein degradation mechanism","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"2026073103245791700_cit12","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/antibiotics11121717","article-title":"A perspective\non newly emerging proteolysis-targeting\nstrategies in antimicrobial drug discovery","volume":"11","author":"Venkatesan","year":"2022","journal-title":"Antibiotics"},{"key":"2026073103245791700_cit13","doi-asserted-by":"publisher","first-page":"116202","DOI":"10.1016\/j.ejmech.2024.116202","article-title":"Design, synthesis,\nand biological evaluation of first-in-class indomethacin-based PROTACs\ndegrading SARS-CoV-2 main protease and with broad-spectrum antiviral\nactivity","volume":"268","author":"Desantis","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"40","key":"2026073103245791700_cit14","doi-asserted-by":"publisher","first-page":"2405829","DOI":"10.1002\/advs.202405829","article-title":"Discovery of Potent Degraders of\nthe Dengue Virus Envelope Protein","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"2026073103245791700_cit15","doi-asserted-by":"publisher","first-page":"107535","DOI":"10.1016\/j.isci.2023.107535","article-title":"PROTAC targeting cyclophilin A controls\nvirus-induced cytokine storm","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"issue":"23","key":"2026073103245791700_cit16","doi-asserted-by":"publisher","first-page":"12858","DOI":"10.3390\/ijms222312858","article-title":"Development of a PROTAC-based\ntargeting strategy\nprovides a mechanistically unique mode of anti-cytomegalovirus activity","volume":"22","author":"Hahn","year":"2021","journal-title":"IJMS"},{"issue":"3","key":"2026073103245791700_cit17","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.cellin.2022.100030","article-title":"Discovery\nof oseltamivir-based novel PROTACs as degraders targeting neuraminidase\nto combat H1N1 influenza virus","volume":"1","author":"Xu","year":"2022","journal-title":"Cell Insight"},{"key":"2026073103245791700_cit18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-981-16-0267-2_13","article-title":"Exploiting ubiquitin\nligases for induced target degradation as an antiviral strategy","volume-title":"Antiviral Drug Discovery And Development","author":"Verma","year":"2021"},{"issue":"21","key":"2026073103245791700_cit19","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.1080\/07391102.2021.1953601","article-title":"Protein degradation:\na novel computational\napproach to design protein degrader probes for main protease of SARS-CoV-2","volume":"40","author":"Shaheer","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"2026073103245791700_cit20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29926","article-title":"Harnessing PROTACs\nto combat H5N1 influenza: A new\nfrontier in viral destruction","volume":"96","author":"Mukerjee","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"2026073103245791700_cit21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-biochem-032620-104421","article-title":"Driving E3 ligase substrate\nspecificity for targeted\nprotein degradation: lessons from nature and the laboratory","volume":"91","author":"Cowan","year":"2022","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"2026073103245791700_cit22","doi-asserted-by":"publisher","first-page":"104032","DOI":"10.1016\/j.drudis.2024.104032","article-title":"The impact\nof E3 ligase choice on\nPROTAC effectiveness in protein kinase degradation","volume":"29","author":"Sobierajski","year":"2024","journal-title":"Drug Discovery Today"},{"issue":"12","key":"2026073103245791700_cit23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1021\/acscentsci.6b00280","article-title":"Protein\ndegradation by in-cell self-assembly of proteolysis targeting chimeras","volume":"2","author":"Lebraud","year":"2016","journal-title":"ACS Cent. Sci."},{"issue":"3","key":"2026073103245791700_cit24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1039\/D3CB00199G","article-title":"Click chemistry\nin the development\nof PROTACs","volume":"5","author":"Yang","year":"2024","journal-title":"RSC Chem. Biol."},{"issue":"12","key":"2026073103245791700_cit25","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1021\/acs.jmedchem.1c00482","article-title":"Unraveling\nthe role of linker design\nin proteolysis targeting chimeras: Miniperspective","volume":"64","author":"Bemis","year":"2021","journal-title":"J. Med. Chem."},{"issue":"21","key":"2026073103245791700_cit26","doi-asserted-by":"publisher","first-page":"14276","DOI":"10.1021\/acs.jmedchem.2c01159","article-title":"Blocking Non-enzymatic\nFunctions by PROTAC-Mediated Targeted Protein Degradation","volume":"65","author":"Sun","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073103245791700_cit27","doi-asserted-by":"publisher","first-page":"108371","DOI":"10.1016\/j.pharmthera.2023.108371","article-title":"Novel strategies\nand promising opportunities for targeted protein degradation: An innovative\ntherapeutic approach to overcome cancer resistance","volume":"244","author":"Zhu","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"2026073103245791700_cit28","doi-asserted-by":"publisher","first-page":"116629","DOI":"10.1016\/j.ejmech.2024.116629","article-title":"Development\nof novel antivrial agents that induce the degradation of the main\nprotease of human-infecting coronaviruses","volume":"275","author":"Cheng","year":"2024","journal-title":"Eur.\nJ. Med. Chem."},{"issue":"8","key":"2026073103245791700_cit29","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1021\/acs.jmedchem.3c02416","article-title":"Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease","volume":"67","author":"Alugubelli","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026073103245791700_cit30","doi-asserted-by":"publisher","first-page":"1132501","DOI":"10.3389\/fmicb.2023.1132501","article-title":"Therapeutic\ndevelopments for SARS-CoV-2 infection-Molecular\nmechanisms of action of antivirals and strategies for mitigating resistance\nin emerging variants in clinical practice","volume":"14","author":"Sa\u0306ndulescu","year":"2023","journal-title":"Front.\nMicrobiol."},{"issue":"2","key":"2026073103245791700_cit31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein\ndegradation: an emerging drug discovery\nparadigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"9","key":"2026073103245791700_cit32","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.drudis.2020.06.015","article-title":"Degraders\nearly developability assessment:\nface-to-face with molecular properties","volume":"25","author":"Ermondi","year":"2020","journal-title":"Drug\nDiscovery Today"},{"issue":"8","key":"2026073103245791700_cit33","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1021\/acsmedchemlett.4c00189","article-title":"Interplay of PROTAC\nComplex Dynamics for Undruggable\nTargets: Insights into Ternary Complex Behavior and Linker Design","volume":"15","author":"Kumar","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"2026073103245791700_cit34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4155\/fmc-2021-0208","article-title":"PROTAC cell permeability\nand oral bioavailability:\na journey into uncharted territory","volume":"14","author":"Poongavanam","year":"2022","journal-title":"Taylor Francis"},{"issue":"9","key":"2026073103245791700_cit35","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space\nbeyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem. Biol."},{"issue":"10","key":"2026073103245791700_cit36","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1039\/C9MD00272C","article-title":"Developing\ndegraders: principles and perspectives on design and chemical space","volume":"10","author":"Maple","year":"2019","journal-title":"MedChemcomm"},{"issue":"13","key":"2026073103245791700_cit37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bmcl.2019.04.030","article-title":"Proteolysis\ntargeting chimeras (PROTACs)\nin \u2018beyond rule-of-five\u2019chemical space: Recent progress\nand future challenges","volume":"29","author":"Edmondson","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"2026073103245791700_cit38","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1016\/j.apsb.2024.04.007","article-title":"Characteristic roadmap of linker\ngoverns the rational design of PROTACs","volume":"14","author":"Dong","year":"2024","journal-title":"Acta\nPharm. Sin. B"},{"issue":"1","key":"2026073103245791700_cit39","doi-asserted-by":"publisher","first-page":"115228","DOI":"10.1016\/j.bmc.2019.115228","article-title":"Discovery of a new class of PROTAC BRD4 degraders based on a dihydroquinazolinone\nderivative and lenalidomide\/pomalidomide","volume":"28","author":"Zhang","year":"2020","journal-title":"Bioorg.\nMed. Chem."},{"issue":"1","key":"2026073103245791700_cit40","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41467-025-56317-8","article-title":"Macrocycle-based PROTACs selectively degrade\ncyclophilin A and inhibit HIV-1 and HCV","volume":"16","author":"Newton","year":"2025","journal-title":"Nat.\nCommun."},{"issue":"1","key":"2026073103245791700_cit41","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1038\/s41467-023-39904-5","article-title":"Affinity\nand cooperativity modulate ternary complex formation to drive targeted\nprotein degradation","volume":"14","author":"Wurz","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"2026073103245791700_cit42","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","article-title":"BAF complex vulnerabilities in cancer\ndemonstrated via structure-based PROTAC design","volume":"15","author":"Farnaby","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"2026073103245791700_cit43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/acsbiomedchemau.2c00037","article-title":"Modeling the\nEffect\nof Cooperativity in Ternary Complex Formation and Targeted Protein\nDegradation Mediated by Heterobifunctional Degraders","volume":"3","author":"Park","year":"2023","journal-title":"ACS Bio Med. Chem. Au"},{"key":"2026073103245791700_cit44","unstructured":"Bothe, J. R.; Brunskill, A. P. J.; Lockwood, M.; Newman, J. A.; Saindane, M. T.,  Novel forms of antiviral\nnucleosidesWO 2,022,047,229 A1."},{"issue":"19","key":"2026073103245791700_cit45","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1021\/acs.jmedchem.2c00877","article-title":"Linker-dependent folding\nrationalizes PROTAC cell permeability","volume":"65","author":"Poongavanam","year":"2022","journal-title":"J. Med.\nChem."},{"issue":"35","key":"2026073103245791700_cit46","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1016\/j.tet.2016.07.044","article-title":"Advances of azide-alkyne\ncycloaddition-click\nchemistry over the recent decade","volume":"72","author":"Singh","year":"2016","journal-title":"Tetrahedron"},{"key":"2026073103245791700_cit47","first-page":"1","article-title":"Discovery\nstudio","volume":"420","author":"Studio","year":"2008","journal-title":"Accelrys [2.1]"},{"issue":"1","key":"2026073103245791700_cit48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/prot.10389","article-title":"ZDOCK: an initial-stage protein-docking algorithm","volume":"52","author":"Chen","year":"2003","journal-title":"Proteins: struct., Funct., Bioinf."},{"issue":"2","key":"2026073103245791700_cit49","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1021\/ci060094h","article-title":"Recore: a fast and\nversatile method for scaffold hopping based on small molecule crystal\nstructure conformations","volume":"47","author":"Maass","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"2026073103245791700_cit50","first-page":"105","article-title":"Analysis of\naptamer-small molecule binding interactions using isothermal titration\ncalorimetry","volume-title":"Nucleic Acid Aptamers: selection,\nCharacterization, and Application","author":"Slavkovic","year":"2022"},{"issue":"15","key":"2026073103245791700_cit51","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202400225","article-title":"Kinetic ITC of DNA\nAptamers binding for small molecules and implications\nfor binding assays and biosensors","volume":"25","author":"Ding","year":"2024","journal-title":"ChemBiochem"},{"issue":"16","key":"2026073103245791700_cit52","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1021\/ja311795d","article-title":"A comprehensive\nmathematical model for three-body binding equilibria","volume":"135","author":"Douglass","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"2026073103245791700_cit53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0958-1669(99)00054-3","article-title":"Advances in surface plasmon resonance biosensor analysis","volume":"11","author":"Rich","year":"2000","journal-title":"Curr. Opin. Biotechnol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c02065","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/21\/23247\/66301062\/acs.jmedchem.5c02065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/21\/23247\/66301062\/acs.jmedchem.5c02065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:25:06Z","timestamp":1785482706000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/21\/23247\/5235111\/Structure-Informed-Design-of-High-Cooperativity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":53,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2025,11,13]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02065.s008","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}